MCOW
Pacer S&P MidCap 400 Quality FCF Aristocrats ETF
Pacer S&P MidCp 400 Qul FCF Arstcrts ETF seeks to provide investment results that correspond to the performance of an index comprised of mid-cap companies exhibiting strong free cash flow characteristics.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 1.1 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Aug 27, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| PURE STORAGE, INC. CLASS A | 5.1 % |
| STERLING CONSTRUCTION CO | 4.3 % |
| LATTICE SEMICONDUCTOR CORP | 4.3 % |
| RAMBUS INC | 3.7 % |
| DOCUSIGN, INC. | 3.4 % |
| MANHATTAN ASSOCIATES INC | 2.9 % |
| MEDPACE HOLDINGS, INC. | 2.8 % |
| EXELIXIS INC | 2.5 % |
| NEUROCRINE BIOSCIENCES INC | 2.4 % |
| JAZZ PHARMACEUTICALS PLC | 2.4 % |
Constituent Breakdown
| Number of holdings | 79 |
| Herfindahl-Hirschman Index | 202 |
| Wgt avg mkt cap (mns) | $10,204 |
| Large cap (>$10bn) | 50.4% |
| Mid cap ($2-10bn) | 48.3% |
| Small cap (<$2bn) | 1.0% |
| Developed mkts. | 99.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.0 % |
 |
IRELAND | 2.4 % |
 |
BRITAIN | 2.0 % |
 |
CANADA | 1.8 % |
 |
BERMUDA | 1.7 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 6.9% | -- | -- | -- | -- | -- | -- | 2.9% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 0.1% |
| Total Returns | 7.0% | -- | -- | -- | -- | -- | -- | 3.1% | Ann. Volatility | 18.6% | -- | -- | -- | -- | -- | -- | 17.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 4.0% |
| Avg. Bid/Ask (% of price) | 0.22% |
Technical Indicators
| 30d moving avg. (EMA) | $20.17 |
| Relative strength (RSI) | 62 |
| MACD/Signal | 0.33/0.30 |
| Bollinger Bands (Upper/Lower) | $21.12/$19.66 |
| Short interest (% of AUM) | 3.6% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MCOW |
Expenses vs. MCOW |
ALTAR Score™ vs. MCOW |
|---|---|---|---|---|
| XMHQ | Invesco S&P MidCap Quality ETF | 29.4% | -24 bp | -0.2% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 26.9% | -32 bp | -2.4% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 26.8% | -39 bp | -2.4% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 26.8% | -34 bp | -2.4% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 24.9% | -14 bp | -1.8% |
| BUL | Pacer US Cash Cows Growth ETF | 22.3% | +11 bp | -1.8% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 21.5% | -37 bp | -0.6% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 20.8% | -34 bp | -0.4% |
| MIDE | Xtrackers S&P MidCap 400 ESG ETF | 20.6% | -34 bp | +0.2% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 20.1% | -26 bp | -0.6% |
Risk and Returns: MCOW vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.1%
ALTAR SCORE™
81st
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. MCOW's ALTAR Score™ is approximately 0.9 standard
deviations above the category average. This places MCOW in the 81st percentile
among funds in the category.
Sell-Side Consensus
$23.69
PRICE TARGET
+11.1%
UPSIDE